DrugPatentWatch Database Preview
Epizyme Inc Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for EPIZYME INC, and when can generic versions of EPIZYME INC drugs launch?
EPIZYME INC has one approved drug.
There are thirteen US patents protecting EPIZYME INC drugs.
There are one hundred and eighty-five patent family members on EPIZYME INC drugs in thirty-seven countries.
Summary for Epizyme Inc
| International Patents: | 185 |
| US Patents: | 13 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Epizyme Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | 8,410,088 | Start Trial | Y | Y | Start Trial | ||
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | 9,855,275 | Start Trial | Start Trial | ||||
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | 9,522,152 | Start Trial | Start Trial | ||||
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | 10,369,155 | Start Trial | Start Trial | ||||
| Epizyme Inc | TAZVERIK | tazemetostat hydrobromide | TABLET;ORAL | 211723-001 | Jan 23, 2020 | RX | Yes | Yes | 10,155,002 | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Epizyme Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Denmark | 2836491 | Start Trial |
| Israel | 265437 | Start Trial |
| Taiwan | I651303 | Start Trial |
| Israel | 266165 | Start Trial |
| New Zealand | 700761 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
